Search Results - "Qi, Ziping"

Refine Results
  1. 1

    Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities by Hu, Chen, Yang, Jing, Qi, Ziping, Wu, Hong, Wang, Beilei, Zou, Fengming, Mei, Husheng, Liu, Jing, Wang, Wenchao, Liu, Qingsong

    Published in MedComm (2020) (01-09-2022)
    “…The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both prokaryotic and eukaryotic organisms, and they maintain cellular…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours by Liu, Juan, Gao, Jingjing, Wang, Aoli, Jiang, Zongru, Qi, Shuang, Qi, Ziping, Liu, Feiyang, Yu, Kailin, Cao, Jiangyan, Chen, Cheng, Hu, Chen, Wu, Hong, Wang, Li, Wang, Wenchao, Liu, Qingsong, Liu, Jing

    Published in Molecular oncology (01-04-2022)
    “…Drug resistance remains a major challenge in the clinical treatment of gastrointestinal stromal tumours (GISTs). While acquired on‐target mutations of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent by Jiang, Zongru, Wang, Li, Liu, Xuesong, Chen, Cheng, Wang, Beilei, Wang, Wenliang, Hu, Chen, Yu, Kailin, Qi, Ziping, Liu, Qingwang, Wang, Aoli, Liu, Jing, Hong, Guangchen, Wang, Wenchao, Liu, Qingsong

    Published in Acta pharmaceutica Sinica. B (01-03-2020)
    “…Angiogenesis is an essential process in tumor growth, invasion and metastasis. VEGF receptor 2 (VEGFR2) inhibitors targeting tumor angiogenic pathway have been…”
    Get full text
    Journal Article
  7. 7

    Infiltrating neutrophils aggravate metabolic liver failure in fah-deficient mice by Qi, Ziping, Wang, Xin, Wei, Haiming, Sun, Rui, Tian, Zhigang

    Published in Liver international (01-03-2015)
    “…Background & Aims Mice deficient in tyrosine catabolic enzyme fumarylacetoacetate hydrolase (fah−/−) was a useful animal model for studying liver failure…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus by Wang, Junjie, Qi, Ziping, Wu, Yun, Wang, Aoli, Liu, Qingwang, Zou, Fengming, Wang, Beilei, Qi, Shuang, Cao, Jiangyan, Hu, Chen, Shi, Chenliang, Liang, Qianmao, Wang, Li, Liu, Jing, Wang, Wenchao, Liu, Qingsong

    Published in Signal transduction and targeted therapy (05-04-2023)
    “…Insulin-producing pancreatic β cell death is the fundamental cause of type 1 diabetes (T1D) and a contributing factor to type 2 diabetes (T2D). Moreover,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in mice by Qi, Ziping, Li, Lu, Wang, Xuefu, Gao, Xiang, Wang, Xin, Wei, Haiming, Zhang, Jian, Sun, Rui, Tian, Zhigang

    Published in PloS one (05-09-2014)
    “…Liver immunopathologic mechanisms during hepatotropic infection, malignant transformation, and autoimmunity are still unclear. Establishing a chimeric mouse…”
    Get full text
    Journal Article
  13. 13

    Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs) by Yu, Kailin, Liu, Xuesong, Jiang, Zongru, Hu, Chen, Zou, Fengming, Chen, Cheng, Ge, Juan, Wu, Jiaxin, Liu, Xiaochuan, Wang, Aoli, Wang, Wenliang, Wang, Wenchao, Qi, Ziping, Wang, Beilei, Wang, Li, Yan, Hezhong, Wang, Jiaoxue, Ren, Tao, Tang, Jun, Liu, Qingsong, Liu, Jing

    Published in Oncotarget (19-12-2017)
    “…KIT kinase V559D mutation is the most prevalent primary gain-of-function mutation in Gastrointestinal Stromal Tumors (GISTs). Here we reported a highly…”
    Get full text
    Journal Article
  14. 14

    Discovery of Pyrazolo1,5-apyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors by Wang, Chun, Zou, Fengming, Qi, Ziping, Liu, Qingwang, Shen, Lijuan, Yuan, Xinyu, Deng, Maoqing, Wang, Aoli, Wang, Beilei, Wang, Li, Liang, Xiaofei, Liu, Qingsong, Liu, Jing

    Published in Journal of medicinal chemistry (12-09-2024)
    “…PI3Kγ and PI3Kδ plays critical roles in exerting immunosuppression by targeting regulatory T cells and myeloid cells. Dual inhibition of PI3Kγ and PI3Kδ has…”
    Get full text
    Journal Article
  15. 15

    Discovery of Pyrazolo[1,5- a ]pyridine Derivatives as Potent and Selective PI3Kγ/δ Inhibitors by Wang, Chun, Zou, Fengming, Qi, Ziping, Liu, Qingwang, Shen, Lijuan, Yuan, Xinyu, Deng, Maoqing, Wang, Aoli, Wang, Beilei, Wang, Li, Liang, Xiaofei, Liu, Qingsong, Liu, Jing

    Published in Journal of medicinal chemistry (20-08-2024)
    “…PI3Kγ and PI3Kδ plays critical roles in exerting immunosuppression by targeting regulatory T cells and myeloid cells. Dual inhibition of PI3Kγ and PI3Kδ has…”
    Get full text
    Journal Article
  16. 16

    Magnetosome-inspired synthesis of soft ferrimagnetic nanoparticles for magnetic tumor targeting by Ma, Kun, Xu, Shuai, Tao, Tongxiang, Qian, Junchao, Cui, Qiqi, Rehman, Sajid ur, Zhu, Xiaoguang, Chen, Ruiguo, Zhao, Hongxin, Wang, Changhao, Qi, Ziping, Dai, Han, Zhang, Xin, Xie, Can, Lu, Yang, Wang, Hongzhi, Wang, Junfeng

    “…Magnetic targeting is one of the most promising approaches for improving the targeting efficiency by which magnetic drug carriers are directed using external…”
    Get full text
    Journal Article
  17. 17

    Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3Kγ/δ dual inhibitor by Liang, Xiaofei, Deng, Maoqing, Zou, Fengming, Qi, Ziping, Wang, Chun, Liu, Juan, Liu, Qingwang, Wang, Beilei, Qi, Shuang, Ge, Juan, Yu, Hongwei, Wang, Aoli, Liu, Qingsong, Liu, Jing

    Published in European journal of medicinal chemistry (15-11-2023)
    “…Phosphoinositol 3-kinases (PI3Ks) γ and δ are primarily expressed in leukocytes and play crucial roles in regulation of the immune system. Dual inhibition of…”
    Get full text
    Journal Article
  18. 18

    Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment by Wang, Aoli, Liu, Juan, Li, Xixiang, Zou, Fengming, Qi, Ziping, Qi, Shuang, Liu, Qingwang, Wang, Zuowei, Cao, Jiangyan, Jiang, Zongru, Wang, Beilei, Ge, Juan, Wang, Li, Wang, Wenchao, Liu, Jing, Liu, Qingsong

    Published in European journal of pharmacology (05-08-2023)
    “…Although rat sarcoma viral oncogene homolog (RAS) mutations occur in about 30% of solid tumors, targeting RAS mutations other than KRAS-G12C is still…”
    Get full text
    Journal Article
  19. 19

    Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes by Wu, Yun, Qi, Ziping, Wang, Beilei, Wang, Junjie, Liu, Qingwang, Wang, Aoli, Shi, Chenliang, Zhou, Bin, Liang, Qianmao, Wang, Wenliang, Zou, Fengming, Qi, Shuang, Wang, Zuowei, Wang, Li, Wang, Wenchao, Liu, Jing, Liu, Qingsong

    Published in Journal of medicinal chemistry (08-09-2022)
    “…The critical pathogenesis of type 1 diabetes (T1D)/type 2 diabetes (T2D) is the physical status, mass, and function of pancreatic β cells. Mammalian STE20-like…”
    Get full text
    Journal Article
  20. 20